Abstract
Background: LTC4S is required for Orai1/Orai3 LRC channel activation. However, the role of LTC4S in neointimal hyperplasia is unknown. Results: LTC4S knockdown inhibited neointimal hyperplasia. Akt phosphorylation was decreased in injured arteries, and knockdown of Orai3 or LTC4S restored Akt phosphorylation. Conclusion: LTC4S is required for neointimal hyperplasia. Significance: LTC4S is a potential therapeutic target for vascular occlusive diseases.
Original language | English (US) |
---|---|
Pages (from-to) | 5015-5027 |
Number of pages | 13 |
Journal | Journal of Biological Chemistry |
Volume | 290 |
Issue number | 8 |
DOIs | |
State | Published - Feb 20 2015 |
All Science Journal Classification (ASJC) codes
- Biochemistry
- Molecular Biology
- Cell Biology